This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bennett, J. V.
Right arrow Articles by Katz, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bennett, J. V.
Right arrow Articles by Katz, S. L.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrow Miscellaneous

PEDIATRICS Vol. 104 No. 5 November 1999, pp. 1123

COMMENTARY:
Edmonston-Zagreb Measles Vaccine: A Good Vaccine With an Image Problem

The first 20% of the full text of this article appears below.

The high-titered (doses >4.7 log10 infectious units1) measles vaccine era was curtailed abruptly by safety concerns in 1992.2 No new safety issues relevant to measles vaccines have surfaced in the interim, but misunderstandings about the overall safety of one of the vaccines involved in these events, the Edmonston-Zagreb (EZ) strain, appear to us to have persisted and become sufficiently widespread to merit an attempt at clarification. A brief historical review of events may help to disclose the likely origins of this problem.

The high-titer measles vaccine trials involved mainly EZ and Schwarz (SW) vaccines given to young infants. Both SW and EZ are derived from the original Edmonston strain, and differ only in their passage levels and cell substrate---chick embryo fibroblasts and WI-38, respectively.3 EZ was rather consistently and significantly more immunogenic than SW in infants with maternal antibodies, and . . . [Full Text of this Article]